Skip to main content

Find Clinical Trials

Clinical trial condition

MDS

Explore clinical trials studying MDS. Study availability and eligibility vary by location and protocol.

105 public trials 27 recruiting studies

Refine in advanced search Browse all conditions

MDS trial results

Completed

A Study of LDE255 in Combination With Azacitidine for High Risk Myelodysplastic Syndrome Patients

NCT02323139

Conditions: MDS
Locations: CHU d'Amiens Amiens, France

CHU d'Angers Angers, France

CH Henri Duffaut Avignon, France

CH de la Côte Basque Bayonne, France

View all 24 locations

View Trial Details

Completed

Determination of Safe and Effective Dose of Romiplostim (AMG 531) in Subjects With Myelodysplastic Syndrome (MDS)Receiving Hypomethylating Agents

NCT00321711

Conditions: Blood Platelet Disorders, Bone Marrow Diseases, Cytopenia, +5 more
Locations: Not specified

View Trial Details

Completed

Ultra-Low Dose IL-2 Therapy as GVHD Prophylaxis in Haploidentical Allogeneic Stem Cell Transplantation

NCT02226861

Conditions: Acute Lymphoblastic Leukemia (ALL), Acute Myelogenous Leukemia (AML), Bone Marrow Diseases, +24 more
Locations: National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States

View Trial Details

Completed

Evaluating the Safety of Long Term Dosing of Romiplostim (Formerly AMG 531) in Thrombocytopenic Subjects With Myelodysplastic Syndromes (MDS)

NCT00472290

Conditions: Blood Platelet Disorders, Bone Marrow Diseases, Cytopenia, +6 more
Locations: Not specified

View Trial Details

Completed

Darbepoetin Alfa in Patients With Anemic Low or Intermediate-1 Risk Myelodysplastic Syndrome (MDS)

NCT01362140

Conditions: Bone Marrow Diseases, Hematologic Diseases, Hemic and Lymphatic Diseases, +2 more
Locations: Research Site Innsbruck, Austria

Research Site Linz, Austria

Research Site Salzburg, Austria

Research Site Vienna, Austria

View all 72 locations

View Trial Details

Completed

Ganciclovir by Infusion and by Mouth in Treating Patients With Cytomegalovirus After Donor Bone Marrow Transplant

NCT00530218

Conditions: Blood Protein Disorders, Bone Marrow Diseases, Cardiovascular Diseases, +21 more
Locations: City of Hope National Medical Center Duarte, California, United States

View Trial Details

Completed

Donor Lymphocyte Infusion (DLI) for Relapsed (Post Transplant) Leukemia

NCT00167167

Conditions: AML, Bone Marrow Diseases, Chronic Disease, +21 more
Locations: University of Minnesota Medical Center Minneapolis, Minnesota, United States

View Trial Details

Completed

Unrelated Umbilical Cord Blood Transplantation Augmented With ALDHbr Umbilical Cord Blood Cells

NCT00692926

Conditions: Anemia, Anemia, Aplastic, Bone Marrow Diseases, +33 more
Locations: Duke University Medical Center Durham, North Carolina, United States

View Trial Details

Completed

Efficacy and Safety of Oral Rigosertib in Transfusion-dependent, Low or Int-1 or Trisomy 8 Int-2 Myelodysplastic Syndrome

NCT01584531

Conditions: Bone Marrow Diseases, Chromosome 8, trisomy, Hematologic Diseases, +5 more
Locations: Mayo Clinic Scottsdale, Arizona, United States

Winship Cancer Institute, Emory University Atlanta, Georgia, United States

Mayo Clinic Rochester, Minnesota, United States

Columbia University Medical Center New York, United States

View Trial Details

Completed

Nonmyeloablative Allo SCT for the Treatment of Hematologic Disorders

NCT00636909

Conditions: ALL, AML, Anemia, +40 more
Locations: Not specified

View Trial Details